| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Talis Biomedical (NASDAQ:TLIS) is set to give its latest quarterly earnings report on Thursday, 2023-08-10. Here's what investors need to know before the announcement.
Analysts estimate that Talis Biomedical will report an earnings per share (EPS) of $-0.73.
Talis Biomedical bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Last quarter the company beat EPS by $1.05, which was followed by a 11.62% drop in the share price the next day.
Here's a look at Talis Biomedical's past performance and the resulting price change:
| Quarter | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|
| EPS Estimate | -10.95 | -10.20 | -10.95 | -12 |
| EPS Actual | -9.90 | -15.15 | -14.70 | -15.15 |
| Price Change % | -11.62% | -6.08% | -8.23% | 1.44% |
Shares of Talis Biomedical were trading at $7.57 as of August 08. Over the last 52-week period, shares are down 37.09%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Talis Biomedical visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: TLIS
